|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Healthcare providers globally have a universal goal: provide the best patient care at an optimal cost. But healthcare providers face challenges – including blood-related challenges – as they strive to meet this goal. With aging worldwide populations and advances in medical treatments, demand for blood is increasing. Yet supply is not keeping pace with demand. Hospitals sometimes cancel or postpone elective surgeries because blood is not available. And while the blood supply is very safe, there is a growing body of clinical data linking transfusions to complications and adverse reactions, lengthened hospital stays, and increased hospital costs. At more than $1,400 per unit, allogeneic blood is expensive.1 Finally, the blood supply chain is fragmented. Hospitals often do not have robust processes to predict blood demand, optimize blood resources, or track blood from its source at the blood donor center. Despite a safe blood supply, risks still exist
Through internal product development and acquisition, Haemonetics has significantly expanded its product offerings to comprise a full suite of blood management solutions – devices, information management systems, and services – that help our customers improve patient care while reducing costs. Our definition of blood management is simple:
Solutions That Meet Our Customers’ Needs Our Patient Division portfolio helps hospitals determine blood demand and individual patient treatments, implement best practices for blood usage, and reduce costs.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
